Table 2.
All values before and after treatment (n = 12)
| Pre- | Post- | p | |
|---|---|---|---|
| Body weight | |||
| BMI (kg/m2) | 17.7 (16.6, 21.2) | 18.3 (17.1, 20.9) | 0.265 |
| %IBW (%) | 80.3 (75.6, 96.2) | 82.8 (77.8, 95.1) | 0.23 |
| %UBW (%) | 86.8 (83.3, 97.0) | 89.6 (86.6, 95.4) | 0.213 |
| Laboratory tests | |||
| RBC (×104/mm3) | 386 (330, 469) | 398 (377, 440) | 0.308 |
| Hb (g/dL) | 11.3 (9.4, 11.9) | 11.6 (11.1, 12.0) | 0.1 |
| Ht (%) | 35.0 (28.2, 36.8) | 35.1 (33.7, 36.7) | 0.136 |
| WBC (/mm3) | 6700 (6100, 8900) | 5000 (4000, 5700) | 0.041 |
| MCV (fL) | 85.3 (78.4, 86.7) | 87.7 (82.0, 89.0) | 0.117 |
| TLC (/mm3) | 1530 (1134, 2089) | 1837 (1636, 2113) | 0.099 |
| Plt (×103/mm3) | 438 (404, 496) | 311 (244, 345) | 0.062 |
| CRP (mg/dL) | 2.36 (1.07, 5.14) | 0.12 (0.04, 0.23) | 0.06 |
| Alb (g/dL) | 3.0 (2.8, 3.3) | 3.6 (3.5, 3.8) | 0.004 |
| Index | |||
| PNI | 38.7 (34.6, 43.1) | 46.1 (45.7, 47.8) | 0.012 |
| CDAI | 221 (163, 286) | 138 (115, 166) | 0.002 |
| Energy metabolism | |||
| REE (kcal/kg/day) | 26.6 (23.4, 30.6) | 24.9 (21.8, 26.6) | 0.084 |
| RQ | 0.82 (0.80, 0.85) | 0.86 (0.84, 0.95) | 0.003 |
| Fat oxidation (kcal/kg/day) | 14.7 (13.3, 16.9) | 9.4 (4.3, 12.2) | 0.002 |
| Carbohydrate oxidation (kcal/kg/day) | 8.7 (7.5, 14.8) | 13.2 (9.2, 21.5) | 0.008 |
| Inflammatory cytokines | |||
| TNF-α (pg/dL) | 2.1 (1.8, 2.5) | 2.2 (1.4, 3.8) | 0.185 |
| IL-6 (pg/dL) | 10.7 (6.2, 14.7) | 3.0 (2.1, 4.1) | 0.091 |
BMI, body mass index; %IBW, % ideal body weight; %UBW, % usual body weight; RBC, red blood cell count; Hb, hemoglobin; Ht, hematocrit; WBC, white blood cell count; MCV, mean corpuscular volume; TLC, total lymphocyte count; Plt, platelets; CRP, C-reactive protein; Alb, albumin; CDAI, Crohn disease activity index; PNI, prognostic nutritional index; REE, resting energy expenditure; RQ, respiratory quotient; TNF-α, tumor necrosis factor α; IL-6, interleukin-6. Values are expressed asmedian (25% quartile, 75% quartile).